Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

OFIX ALERT: Hagens Berman Notifies Orthofix Medical (OFIX) Shareholders of Investigation into Events Leading to Termination of Senior Management

OFIX

SAN FRANCISCO, CA / ACCESSWIRE / October 11, 2023 / Hagens Berman urges Orthofix Medical Inc. (NASDAQ:OFIX) investors who suffered substantial losses to submit your losses now. The Firm also encourages persons with knowledge that might assist the investigation to contact its attorneys.

Visit:www.hbsslaw.com/investor-fraud/ofix

Contact An Attorney Now:OFIX@hbsslaw.com

844-916-0895

Orthofix Medical Inc. (OFIX) Investigation:

The investigation focuses on Orthofix's recent assurances that "[i]t is our fundamental policy to conduct business in accordance with the highest ethical and legal standards."

On Sept. 12, 2023, Orthofix abruptly terminated CEO Keith Valentine, CFO John Bostjancic, and Chief Legal Officer Patrick Keran "for cause." The company explained that "the Board determined that each of these executives engaged in repeated inappropriate and offensive conduct that violated multiple code of conduct requirements and was inconsistent with the Company's values and culture."

In response to this news, certain analysts downgraded Orthofix and the price of Orthofix sharply fell that day.

"We're focused on investors' losses and investigating whether Orthofix may have misled investors about its commitment to comply with its Ethics and Compliance program," said Reed Kathrein, the Hagens Berman partner leading the investigation.

If you invested in Orthofix Medical and have substantial losses, or have knowledge that may assist the firm's investigation, click here to discuss your legal rights with Hagens Berman.

Whistleblowers: Persons with non-public information regarding Orthofix Medical should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at 844-916-0895 or email OFIX@hbsslaw.com.

# # #

About Hagens Berman
Hagens Berman is a global plaintiffs' rights complex litigation law firm focusing on corporate accountability through class-action law. The firm is home to a robust securities litigation practice and represents investors as well as whistleblowers, workers, consumers and others in cases achieving real results for those harmed by corporate negligence and fraud. More about the firm and its successes can be found at hbsslaw.com. Follow the firm for updates and news at @ClassActionLaw.

Attorney advertising.
Past results do not guarantee future outcomes.
Services may be performed by attorneys in any of our offices.

Contact:
Reed Kathrein, 844-916-0895

SOURCE: Hagens Berman Sobol Shapiro LLP



View source version on accesswire.com:
https://www.accesswire.com/792155/ofix-alert-hagens-berman-notifies-orthofix-medical-ofix-shareholders-of-investigation-into-events-leading-to-termination-of-senior-management



Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today